Omnia Health is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Better experiences and improved outcomes with AI

Video-Better experiences and improved outcomes with AI

Data is quickly becoming the new currency in healthcare led by organisations that prioritise secure storage, clinical interpretation, and the frictionless movement of data between patients and doctors. Dr. David Rhew, Global Chief Medical Officer & VP of Healthcare, Microsoft, USA, has spoken at large about engaging clinicians and patients in the digital age and about the power of data. Artificial intelligence integration in healthcare has witnessed an acceleration in recent years and topics on how it could be positioned to create better experiences for both patients and providers are emerging as a key point of discussion. 

In the 2023 edition of Florida International Medical Expo (FIME), Dr. Rhew, will focus on how AI improves outcomes at both the individual and the population level, and high impact use cases such as clinical and clinician workforce crisis, and ways that the overall efficiency of healthcare can be improved through data waste management. He will also highlight how organisations and individuals can apply AI responsibly. 

 

Emerging AI technologies and trends 

Newer technologies in the market such as ambient clinical intelligence (ACI) will transform experiences for both patients and providers.  
“During a doctor’s visit, the physician usually types in notes during the consultation with the patient that goes into the electronic health record. With ambient clinical intelligence, the doctor and patient can have a conversation and at the end of that experience, everything is captured, codified, and brought into the format of a clinical progress note,” Dr. Rhew explained. 

The clinician can review, edit, and hit a button to bring it directly into the medical record. This is not only an incredible time saver for the clinician, but also improves the patient experience during that interaction.  

“That is just one example of how natural language processing is being used in healthcare to be able to help us create these better experiences. We have witnessed this not just with voice, but with text and images as well.  With generative AI, there is an opportunity for this type of artificial intelligence to be applied in so many different ways,” added Dr. Rhew 

 

Ethical considerations and challenges  

When it comes to the world of data, the process of collaboration and communication is typically in the form of de-identification, which is the process of removing details about a patient that, alone or in conjunction with other details used to identify that patient. “You can strip out the name and some of the unique identifiers. But for some of these datasets, such as genomics, you really cannot de-identify. This is the type of information that inherently needs to be highly secure and kept private,” said the Global Chief Medical Officer. 

One of the challenges with centralised data sharing is the increasing risk of cyberattacks. “An exciting technology that allows us to ensure privacy-protected collaboration is confidential compute where data can be brought together and computed in a secure enclave,” he added. 

In this case, the processing is done directly in the microchip to ensure that the data does not get exposed to third parties, or even to the developers.  

From an AI perspective, Dr. Rhew explained that datasets developed by software developers may be subject to subconscious bias. Also, data sets, if not large enough and diverse enough may not be generalisable and representative of specific sub-populations. 

“These are the areas where we, as an industry, need to start thinking about how we can develop responsible AI practices that will allow us to be able to ensure that AI is implemented responsibly,” he explains. 

Dr. David Rhew will speak on ‘Better experiences and improved outcomes with AI’ at the Transformation Talks on Wednesday, June 21 at Florida International Medical Expo (FIME) in Miami. 

This article appears in Omnia Health magazine. Read the full issue online today.
 
Back to Technology
Webinars and Reports

Trends redefining the medical laboratory industry in 2023

White-paper-Trends redefining the medical laboratory industry in 2023

Medlab Middle East is the premier medical laboratory exhibition and conference in the region, providing a dynamic platform where industry professionals, innovators, and experts converge to showcase the latest advancements in laboratory medicine. 

In this post show report, gain valuable insights into the latest advancements, technologies, and strategies shaping the future of diagnostics. Stay ahead of the curve, optimize your laboratory operations, and unlock new opportunities for growth in the ever-evolving landscape of medical diagnostics.

Download the report now and prepare your lab for success in the dynamic world of healthcare:

 

Having trouble viewing the form? Click here.


Omnia Health logoInterested in content sponsorship opportunities? Get in touch and enquire today.

Medication errors and diversion: a global crisis and the path to prevention

Article-Medication errors and diversion: a global crisis and the path to prevention

Globally, medication errors and diversion have a significant economic impact, costing hospitals, medical insurers, and the world economy hundreds of billions USD annually.

In the United States alone, medication errors cause at least one death every day and injure approximately 1.3 million people, while the estimated impact on low- and middle-income countries is about twice as much.

There are multiple factors that contribute to the prevalence of these critical issues; however, a common underlying cause is a human error and the need to minimize manual processes while improving accuracy through barcode scanning and automated packaging and dispensing systems.

In fact, studies have shown that implementing an automated dispensing system with barcode verification results in an over 50% reduction rate in medication dispensing errors and medication diversion.

The importance of selecting the right partner when seeking solutions cannot be overstated. Implementing effective systems requires expertise and a provider who understands the unique challenges of the healthcare industry.

Accu-Chart®, a trusted name in the global healthcare industry for over 45 years, specializes in providing systems to reduce medication errors and diversion. Our approach encompasses a range of flexible solutions, starting from the pharmacy and extending throughout the facility.

Beginning with the implementation of unit-dose packaging and labelling of drugs with barcodes, we help healthcare providers enhance efficiency, reduce costs, and ultimately improve patient outcomes.

FIME pic 1 - Three Steps.png

A nivel mundial, los errores de medicación y el desvío tienen un impacto económico significativo, que cuesta a los hospitales, las aseguradoras médicas y la economía mundial, cientos de miles de millones de dólares al año.

Solo en los Estados Unidos, los errores de medicación causan al menos una muerte cada día y lesionan a aproximadamente 1,3 millones de personas, mientras que el impacto estimado en los países de ingresos bajos y medianos es aproximadamente el doble.

Existen múltiples factores que contribuyen a la prevalencia de estos problemas críticos; sin embargo, una causa subyacente común es el error humano y la necesidad de minimizar los procesos manuales mientras se mejora la precisión a través del escaneo de códigos de barras y los sistemas automatizados de envasado y distribución.

De hecho, los estudios han demostrado que la implementación de un sistema de dispensación automatizado con verificación de código de barras da como resultado una tasa de reducción de más del 50 % en los errores de dispensación de medicamentos y el desvío de medicamentos.

No se puede exagerar la importancia de seleccionar el socio adecuado cuando se buscan soluciones. La implementación de sistemas efectivos requiere experiencia y un proveedor que comprenda los desafíos únicos de la industria de la salud.

Accu-Chart®, un nombre de confianza en la industria mundial de la salud durante más de 45 años, se especializa en proporcionar sistemas para reducir los errores y el desvío de medicamentos. Nuestro enfoque abarca una gama de soluciones flexibles, comenzando desde la farmacia y extendiéndose por toda la instalación.

Comenzando con la implementación del empaque de dosis unitaria y el etiquetado de medicamentos con códigos de barras, ayudamos a los proveedores de atención médica a mejorar la eficiencia, reducir costos y, en última instancia, mejorar los resultados de los pacientes.

FIME Cuttin Station pic - Spanish v2.png

Learn more / Aprender más

Para obtener más información sobre nuestros productos innovadores e interactuar con nuestro equipo para analizar necesidades y requisitos específicos, visítenos en el stand U65 en la próxima feria comercial FIME.

Contact us / Contacta con nosotros

Para los distribuidores que buscan asociarse con nosotros, contáctenos hoy para programar una reunión de presentación.

Click here to learn more about Florida International Medical Expo (FIME) 2023

Back to Technology

The link between enhanced health and indoor air quality

Article-The link between enhanced health and indoor air quality

Air quality is an increasingly crucial factor in ensuring optimal healthcare for individuals. The rise in CO2 levels and the release of various contaminants into the air significantly impact the air we breathe. Additionally, modern systems and products contribute to air pollution, resulting in a condition known as sick building syndrome (SBS), which arises from poor air quality caused by ventilation systems in modern buildings.

“Fresh air handling units (FAHUs), designed to bring in and treat air from outside, play a vital role in reducing CO2 levels within buildings. By introducing fresh air, the aim is to minimise CO2 concentration and prevent it from exceeding safe levels. The ASHRAE standards recommend a maximum indoor CO2 level of 1000 ppm, but Dubai has set an even better standard of 800 ppm,” says Yousuf Fakhruddin, CEO, Fakhruddin Properties

However, a challenge arises, particularly in hot and humid regions like Dubai. When humid air from outside is cooled inside the building, moisture content remains, leading to condensation in the ducts. Leaky ducts exacerbate the issue by allowing hot air to mix, resulting in mould formation. This problem manifests shortly after the building becomes operational, as dampness and moisture create an environment conducive to mould growth. Consequently, mould spores are circulated into the apartments, posing a significant health risk by compromising the air quality. Inhabitants of such buildings often experience respiratory difficulties, allergies, and other health problems due to exposure to mould contaminants.

Mr. Yousuf Fakhruddin, CEO, Fakhruddin Properties

Yousuf Fakhruddin, CEO, Fakhruddin Properties

 

The adverse physical effects are not the only concern; mental health can also be affected. Inhaling toxins present in the air can have detrimental effects on the brain. Chemicals, especially volatile organic compounds (VOCs), can cross the blood-brain barrier and impact blood flow and neural activity. “The direct connection between the respiratory system and the brain means that these harmful substances can disrupt the normal functioning of neurons and compromise overall mental well-being,” he explains.

Therefore, it is crucial to address the issue of air contamination caused by mould formation and the presence of volatile organic compounds in indoor environments. By adopting effective measures to mitigate these problems, we can ensure healthier living spaces and promote the well-being of individuals.

Combatting indoor air contaminants

Indoor air quality is a matter of concern as it can contain more than 300 chemicals compared to outdoor air. Modern buildings, designed to seal everything inside, contribute to this issue. Consequently, harmful substances remain trapped until specific systems are employed to eliminate volatile organic compounds (VOCs). This becomes particularly problematic when it comes to newborns and young children who are exposed to these pollutants. Increased cases of allergies and asthma in children could be attributed to these indoor air contaminants, which often go unnoticed.

“To address these pressing issues, a two-fold approach is being implemented. The first involves tackling the problem of ducts, which tend to promote mould growth and the presence of VOCs. The new HEECO2R (Healthy Energy Efficiency and CO2 Removal) system eliminates traditional fresh air handling units (FAHUs) and takes a different approach. Instead of bringing air from outside and cooling it, this innovative system eliminates CO2, VOCs, and humidity. When the air re-enters the system, it is free from CO2, humidity, and VOCs. This method significantly reduces the amount of air required for circulation, leading to a transition from large ducts to smaller pipes. The risk of leakage is mitigated by using more robust pipes, ensuring that mould formation is prevented, and clean air is delivered into the apartments,” Fakhruddin says.

The second system focuses on utilising airside machines initially developed by NASA for manned missions to Mars. This technology, known as Airocide, currently used on space stations, was originally designed to enable food growth in spacecraft with limited resources. In a closed environment, plants emit ethylene gas, which accelerates food ripening but can also lead to spoilage. By effectively eliminating ethylene gas, this technology not only extends the shelf life of food in supermarkets but also eliminates bacteria, viruses, mould, and other organisms, including VOCs. Through a natural process, these contaminants are broken down into basic building blocks of nature: water (H2O) and carbon dioxide (CO2). The result is 99.99998 per cent pure air, with no trapped pollutants.

Both of these systems will be implemented in each apartment of the Maimoon Gardens project by Fakhruddin Properties, providing residents with clean and healthy air. Combining the HEEC02R system, which eliminates CO2 and VOCs, and the airside machine, which breaks down contaminants into harmless components, significantly improves indoor air quality. Additionally, this innovative approach not only prioritises the well-being of individuals but also offers energy-saving benefits.

By addressing the issues related to mould formation, VOCs, and other indoor air pollutants, these systems aim to create a healthier and more comfortable living environment. The integration of advanced technologies and a commitment to safeguarding human health demonstrate a step towards enhancing indoor air quality in modern buildings.

Back to Management